Drug Trial Radar · NCT06300320
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
65
Planned (sponsor's estimate)
Start
May 7, 2024
Primary completion
Nov 2027
Study completion May 2029
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets in patients with chronic graft-versus-host disease
Conditions
- Chronic Graft Versus Host Disease
Interventions
TQ05105 tabletsDrug
Rovadicitinib (TQ05105) is a novel, oral dual JAK 1/2 and Rho-associated kinases (ROCK) 1/2 inhibitor targeting inflammatory and fibrotic components of cGVHD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR) at 24 weeksTime frame: Up to 24 weeks
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Anhui Provincial Hospital
Hefei, Anhui, China · Not yet recruiting
The 940th hospital of joint logistics support force of Chinese people's liberation army
Lanzhou, Gansu, China · Not yet recruiting
Guangzhou First People's Hospital
Guangzhou, Guangdong, China · Not yet recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Not yet recruiting
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
Xiangyang Central Hospital
Xiangyang, Hubei, China · Not yet recruiting
Tai'an Central Hospital
Taian, Shangdong, China · Not yet recruiting
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China · Not yet recruiting
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shannxi, China · Not yet recruiting
Hematology Hospital of the Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China · Not yet recruiting
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
The Affiliated People's Hospital of Ningbo University
Ningbo, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.